Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Sectra Ab LSE:0A0L London Ordinary Share SE0014609061 SECTRA ORD SHS CLASS B
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 335.50 659 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

The MetroHealth System in the US adds digital pathology from Sectra to enterprise

17/11/2020 7:46am

PR Newswire (US)


Sectra Ab (LSE:0A0L)
Historical Stock Chart


From Jul 2020 to Jul 2021

Click Here for more Sectra Ab Charts.

LINKÖPING, Sweden, Nov. 17, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will add its digital pathology module to the Sectra enterprise imaging solution located throughout MetroHealth. This will enable pathologists to read cases from any location, including their homes, and allow for streamlined tumor board meetings and improved cancer care for patients.

"By offering integration of whole scanned slides and radiology images on one platform, Sectra represents a huge step forward in patient care," says Dr. Agnes Loeffler, Department Chair of Pathology at The MetroHealth System. 

The initial implementation will focus on the development of workflows around quality assurance within pathology, seamless integration of pathology with tumor boards, and a teaching and research database for the 13 pathologists and 9 residents at MetroHealth. Efficiencies in these workflows will improve the ability of pathologists to actively participate in patient management teams. The contract was signed in October 2020.

MetroHealth's staff of 7,800 employees provides care at 4 hospitals, 20 health centers, and 40 additional sites in Northeast Ohio. Each active physician holds a faculty appointment at Case Western Reserve University School of Medicine.

Sectra's pathology module received FDA approval in the US in March 2020 and is part of Sectra's enterprise imaging offering. It provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra's enterprise imaging solution and why Sectra PACS is ranked "Best in KLAS" for seven consecutive years at medical.sectra.com.

About Sectra

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit sectra.com. 

For further information, please contact:
Dr. Torbjörn Kronander
CEO and President Sectra AB
+46 (0)705 23 52 27

Marie Ekström Trägårdh
Executive Vice President Sectra AB and President Sectra Imaging IT Solutions
+46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/the-metrohealth-system-in-the-us-adds-digital-pathology-from-sectra-to-enterprise,c3238076

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c2850796

Sectra's digital pathology solution

 

Copyright 2020 PR Newswire

1 Year Sectra Ab Chart

1 Year Sectra Ab Chart

1 Month Sectra Ab Chart

1 Month Sectra Ab Chart
ADVFN Advertorial
Your Recent History
LSE
0A0L
Sectra Ab
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210726 19:23:45